{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,12]],"date-time":"2026-11-12T11:29:57Z","timestamp":1794482997064,"version":"4.9.1"},"reference-count":101,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2016,8,17]],"date-time":"2016-08-17T00:00:00Z","timestamp":1471392000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100003196","name":"Ministero della Salute","doi-asserted-by":"publisher","award":["RC2016"],"award-info":[{"award-number":["RC2016"]}],"id":[{"id":"10.13039\/501100003196","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell. Mol. Life Sci."],"published-print":{"date-parts":[[2017,1]]},"DOI":"10.1007\/s00018-016-2324-9","type":"journal-article","created":{"date-parts":[[2016,8,17]],"date-time":"2016-08-17T13:22:03Z","timestamp":1471440123000},"page":"267-277","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":49,"title":["Vascular smooth muscle cells in Marfan syndrome aneurysm: the broken bricks in the aortic wall"],"prefix":"10.1007","volume":"74","author":[{"given":"Gianluca L.","family":"Perrucci","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erica","family":"Rurali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aoife","family":"Gowran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandro","family":"Pini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlo","family":"Antona","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberto","family":"Chiesa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giulio","family":"Pompilio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrizia","family":"Nigro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2016,8,17]]},"reference":[{"issue":"1","key":"2324_CR1","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1016\/j.cpcardiol.2007.10.001","volume":"33","author":"NM Ammash","year":"2008","unstructured":"Ammash NM, Sundt TM, Connolly HM (2008) Marfan syndrome-diagnosis and management. Curr Probl Cardiol 33(1):7\u201339. doi: 10.1016\/j.cpcardiol.2007.10.001","journal-title":"Curr Probl Cardiol"},{"issue":"6333","key":"2324_CR2","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1038\/352337a0","volume":"352","author":"HC Dietz","year":"1991","unstructured":"Dietz HC, Cutting GR, Pyeritz RE et al (1991) Marfan syndrome caused by a recurrent de novo missense mutation in the fibrillin gene. Nature 352(6333):337\u2013339. doi: 10.1038\/352337a0","journal-title":"Nature"},{"issue":"2","key":"2324_CR3","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1002\/humu.20070","volume":"24","author":"B Loeys","year":"2004","unstructured":"Loeys B, De Backer J, Van Acker P et al (2004) Comprehensive molecular screening of the FBN1 gene favors locus homogeneity of classical Marfan syndrome. Hum Mutat 24(2):140\u2013146. doi: 10.1002\/humu.20070","journal-title":"Hum Mutat"},{"issue":"3","key":"2324_CR4","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1002\/humu.10249","volume":"22","author":"G Collod-Beroud","year":"2003","unstructured":"Collod-Beroud G, Le Bourdelles S, Ades L et al (2003) Update of the UMD-FBN1 mutation database and creation of an FBN1 polymorphism database. Hum Mutat 22(3):199\u2013208. doi: 10.1002\/humu.10249","journal-title":"Hum Mutat"},{"issue":"9","key":"2324_CR5","doi-asserted-by":"publisher","first-page":"1053","DOI":"10.1002\/humu.21525","volume":"32","author":"M Baetens","year":"2011","unstructured":"Baetens M, Van Laer L, De Leeneer K et al (2011) Applying massive parallel sequencing to molecular diagnosis of Marfan and Loeys-Dietz syndromes. Hum Mutat 32(9):1053\u20131062. doi: 10.1002\/humu.21525","journal-title":"Hum Mutat"},{"issue":"4","key":"2324_CR6","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1016\/j.ymgme.2012.07.023","volume":"107","author":"MR Davis","year":"2012","unstructured":"Davis MR, Summers KM (2012) Structure and function of the mammalian fibrillin gene family: implications for human connective tissue diseases. Mol Genet Metab 107(4):635\u2013647. doi: 10.1016\/j.ymgme.2012.07.023","journal-title":"Mol Genet Metab"},{"issue":"4","key":"2324_CR7","doi-asserted-by":"publisher","first-page":"1007","DOI":"10.1086\/302582","volume":"65","author":"I Schrijver","year":"1999","unstructured":"Schrijver I, Liu W, Brenn T et al (1999) Cysteine substitutions in epidermal growth factor-like domains of fibrillin-1: distinct effects on biochemical and clinical phenotypes. Am J Hum Genet 65(4):1007\u20131020. doi: 10.1086\/302582","journal-title":"Am J Hum Genet"},{"issue":"1","key":"2324_CR8","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1172\/JCI117298","volume":"94","author":"T Aoyama","year":"1994","unstructured":"Aoyama T, Francke U, Dietz HC et al (1994) Quantitative differences in biosynthesis and extracellular deposition of fibrillin in cultured fibroblasts distinguish five groups of Marfan syndrome patients and suggest distinct pathogenetic mechanisms. J Clin Invest 94(1):130\u2013137. doi: 10.1172\/JCI117298","journal-title":"J Clin Invest"},{"issue":"7","key":"2324_CR9","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1093\/hmg\/ddg081","volume":"12","author":"P Whiteman","year":"2003","unstructured":"Whiteman P, Handford PA (2003) Defective secretion of recombinant fragments of fibrillin-1: implications of protein misfolding for the pathogenesis of Marfan syndrome and related disorders. Hum Mol Genet 12(7):727\u2013737","journal-title":"Hum Mol Genet"},{"issue":"2","key":"2324_CR10","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1038\/ng1097-218","volume":"17","author":"L Pereira","year":"1997","unstructured":"Pereira L, Andrikopoulos K, Tian J et al (1997) Targetting of the gene encoding fibrillin-1 recapitulates the vascular aspect of Marfan syndrome. Nat Genet 17(2):218\u2013222. doi: 10.1038\/ng1097-218","journal-title":"Nat Genet"},{"issue":"3","key":"2324_CR11","first-page":"803","volume":"142","author":"KA Potter","year":"1993","unstructured":"Potter KA, Hoffman Y, Sakai LY et al (1993) Abnormal fibrillin metabolism in bovine Marfan syndrome. Am J Pathol 142(3):803\u2013810","journal-title":"Am J Pathol"},{"issue":"Suppl 1","key":"2324_CR12","doi-asserted-by":"publisher","first-page":"II329","DOI":"10.1161\/01.cir.0000087660.82721.15","volume":"108","author":"M Nataatmadja","year":"2003","unstructured":"Nataatmadja M, West M, West J et al (2003) Abnormal extracellular matrix protein transport associated with increased apoptosis of vascular smooth muscle cells in marfan syndrome and bicuspid aortic valve thoracic aortic aneurysm. Circulation 108(Suppl 1):II329\u2013II334. doi: 10.1161\/01.cir.0000087660.82721.15","journal-title":"Circulation"},{"issue":"6027","key":"2324_CR13","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1126\/science.1192149","volume":"332","author":"TM Holm","year":"2011","unstructured":"Holm TM, Habashi JP, Doyle JJ et al (2011) Noncanonical TGFbeta signaling contributes to aortic aneurysm progression in Marfan syndrome mice. Science 332(6027):358\u2013361. doi: 10.1126\/science.1192149","journal-title":"Science"},{"issue":"3","key":"2324_CR14","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1083\/jcb.200608167","volume":"176","author":"SS Chaudhry","year":"2007","unstructured":"Chaudhry SS, Cain SA, Morgan A et al (2007) Fibrillin-1 regulates the bioavailability of TGFbeta1. J Cell Biol 176(3):355\u2013367. doi: 10.1083\/jcb.200608167","journal-title":"J Cell Biol"},{"issue":"11","key":"2324_CR15","doi-asserted-by":"publisher","first-page":"e150","DOI":"10.1161\/01.CIR.0000155243.70456.F4","volume":"111","author":"DM Milewicz","year":"2005","unstructured":"Milewicz DM, Dietz HC, Miller DC (2005) Treatment of aortic disease in patients with Marfan syndrome. Circulation 111(11):e150\u2013e157. doi: 10.1161\/01.CIR.0000155243.70456.F4","journal-title":"Circulation"},{"issue":"1","key":"2324_CR16","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1590\/S0102-76382011000100019","volume":"26","author":"SM Yuan","year":"2011","unstructured":"Yuan SM, Jing H (2011) Cystic medial necrosis: pathological findings and clinical implications. Rev Bras Cir Cardiovasc 26(1):107\u2013115","journal-title":"Rev Bras Cir Cardiovasc"},{"issue":"10","key":"2324_CR17","doi-asserted-by":"publisher","first-page":"1810","DOI":"10.1074\/mcp.M700544-MCP200","volume":"7","author":"Z Li","year":"2008","unstructured":"Li Z, Zhao X, Bai S et al (2008) Proteomics identification of cyclophilin A as a potential prognostic factor and therapeutic target in endometrial carcinoma. Mol Cell Proteomics 7(10):1810\u20131823. doi: 10.1074\/mcp.M700544-MCP200","journal-title":"Mol Cell Proteomics"},{"issue":"1","key":"2324_CR18","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1161\/CIRCRESAHA.112.281048","volume":"112","author":"AT Nguyen","year":"2013","unstructured":"Nguyen AT, Gomez D, Bell RD et al (2013) Smooth muscle cell plasticity: fact or fiction? Circ Res 112(1):17\u201322. doi: 10.1161\/CIRCRESAHA.112.281048","journal-title":"Circ Res"},{"issue":"1","key":"2324_CR19","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1161\/01.RES.88.1.37","volume":"88","author":"TE Bunton","year":"2001","unstructured":"Bunton TE, Biery NJ, Myers L et al (2001) Phenotypic alteration of vascular smooth muscle cells precedes elastolysis in a mouse model of Marfan syndrome. Circ Res 88(1):37\u201343","journal-title":"Circ Res"},{"issue":"1","key":"2324_CR20","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1006\/excr.1996.0258","volume":"227","author":"SL Thieszen","year":"1996","unstructured":"Thieszen SL, Dalton M, Gadson PF et al (1996) Embryonic lineage of vascular smooth muscle cells determines responses to collagen matrices and integrin receptor expression. Exp Cell Res 227(1):135\u2013145. doi: 10.1006\/excr.1996.0258","journal-title":"Exp Cell Res"},{"issue":"2","key":"2324_CR21","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1006\/excr.1996.3398","volume":"230","author":"PF Gadson Jr","year":"1997","unstructured":"Gadson PF Jr, Dalton ML, Patterson E et al (1997) Differential response of mesoderm- and neural crest-derived smooth muscle to TGF-beta1: regulation of c-myb and alpha1 (I) procollagen genes. Exp Cell Res 230(2):169\u2013180. doi: 10.1006\/excr.1996.3398","journal-title":"Exp Cell Res"},{"issue":"8","key":"2324_CR22","doi-asserted-by":"publisher","first-page":"1745","DOI":"10.1093\/emboj\/19.8.1745","volume":"19","author":"J Massague","year":"2000","unstructured":"Massague J, Wotton D (2000) Transcriptional control by the TGF-beta\/Smad signaling system. EMBO J 19(8):1745\u20131754. doi: 10.1093\/emboj\/19.8.1745","journal-title":"EMBO J"},{"issue":"29","key":"2324_CR23","doi-asserted-by":"crossref","first-page":"18459","DOI":"10.1074\/jbc.273.29.18459","volume":"273","author":"J Saharinen","year":"1998","unstructured":"Saharinen J, Taipale J, Monni O et al (1998) Identification and characterization of a new latent transforming growth factor-beta-binding protein, LTBP-4. J Biol Chem 273(29):18459\u201318469","journal-title":"J Biol Chem"},{"issue":"4","key":"2324_CR24","doi-asserted-by":"publisher","first-page":"662","DOI":"10.1086\/521409","volume":"81","author":"HC Dietz","year":"2007","unstructured":"Dietz HC (2007) 2006 Curt Stern Award Address. Marfan syndrome: from molecules to medicines. Am J Hum Genet 81(4):662\u2013667. doi: 10.1086\/521409","journal-title":"Am J Hum Genet"},{"issue":"Pt 2","key":"2324_CR25","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1242\/jcs.00229","volume":"116","author":"JP Annes","year":"2003","unstructured":"Annes JP, Munger JS, Rifkin DB (2003) Making sense of latent TGFbeta activation. J Cell Sci 116(Pt 2):217\u2013224","journal-title":"J Cell Sci"},{"issue":"8\u20139","key":"2324_CR26","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1016\/j.ejcb.2008.01.012","volume":"87","author":"PJ Wipff","year":"2008","unstructured":"Wipff PJ, Hinz B (2008) Integrins and the activation of latent transforming growth factor beta1\u2014an intimate relationship. Eur J Cell Biol 87(8\u20139):601\u2013615. doi: 10.1016\/j.ejcb.2008.01.012","journal-title":"Eur J Cell Biol"},{"issue":"5","key":"2324_CR27","doi-asserted-by":"crossref","first-page":"1659","DOI":"10.1083\/jcb.106.5.1659","volume":"106","author":"RM Lyons","year":"1988","unstructured":"Lyons RM, Keski-Oja J, Moses HL (1988) Proteolytic activation of latent transforming growth factor-beta from fibroblast-conditioned medium. J Cell Biol 106(5):1659\u20131665","journal-title":"J Cell Biol"},{"issue":"9","key":"2324_CR28","doi-asserted-by":"publisher","first-page":"1077","DOI":"10.1210\/mend.10.9.8885242","volume":"10","author":"MH Barcellos-Hoff","year":"1996","unstructured":"Barcellos-Hoff MH, Dix TA (1996) Redox-mediated activation of latent transforming growth factor-beta 1. Mol Endocrinol 10(9):1077\u20131083. doi: 10.1210\/mend.10.9.8885242","journal-title":"Mol Endocrinol"},{"issue":"4","key":"2324_CR29","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1083\/jcb.122.4.923","volume":"122","author":"S Schultz-Cherry","year":"1993","unstructured":"Schultz-Cherry S, Murphy-Ullrich JE (1993) Thrombospondin causes activation of latent transforming growth factor-beta secreted by endothelial cells by a novel mechanism. J Cell Biol 122(4):923\u2013932","journal-title":"J Cell Biol"},{"issue":"2","key":"2324_CR30","doi-asserted-by":"publisher","first-page":"446","DOI":"10.1093\/cvr\/cvq291","volume":"89","author":"D Gomez","year":"2011","unstructured":"Gomez D, Coyet A, Ollivier V et al (2011) Epigenetic control of vascular smooth muscle cells in Marfan and non-Marfan thoracic aortic aneurysms. Cardiovasc Res 89(2):446\u2013456. doi: 10.1093\/cvr\/cvq291","journal-title":"Cardiovasc Res"},{"issue":"3","key":"2324_CR31","doi-asserted-by":"publisher","first-page":"807","DOI":"10.1007\/s00441-014-1993-7","volume":"358","author":"DW Howell","year":"2014","unstructured":"Howell DW, Popovic N, Metz RP et al (2014) Regional changes in elastic fiber organization and transforming growth factor beta signaling in aortas from a mouse model of marfan syndrome. Cell Tissue Res 358(3):807\u2013819. doi: 10.1007\/s00441-014-1993-7","journal-title":"Cell Tissue Res"},{"issue":"45","key":"2324_CR32","doi-asserted-by":"publisher","first-page":"14012","DOI":"10.1073\/pnas.1507652112","volume":"112","author":"L Zilberberg","year":"2015","unstructured":"Zilberberg L, Phoon CK, Robertson I et al (2015) Genetic analysis of the contribution of LTBP-3 to thoracic aneurysm in Marfan syndrome. Proc Natl Acad Sci USA 112(45):14012\u201314017. doi: 10.1073\/pnas.1507652112","journal-title":"Proc Natl Acad Sci USA"},{"issue":"1 Suppl","key":"2324_CR33","doi-asserted-by":"publisher","first-page":"I371","DOI":"10.1161\/CIRCULATIONAHA.105.000927","volume":"114","author":"M Nataatmadja","year":"2006","unstructured":"Nataatmadja M, West J, West M (2006) Overexpression of transforming growth factor-beta is associated with increased hyaluronan content and impairment of repair in Marfan syndrome aortic aneurysm. Circulation 114(1 Suppl):I371\u2013I377. doi: 10.1161\/CIRCULATIONAHA.105.000927","journal-title":"Circulation"},{"issue":"9","key":"2324_CR34","doi-asserted-by":"publisher","first-page":"5630","DOI":"10.1074\/jbc.M806962200","volume":"284","author":"L Carta","year":"2009","unstructured":"Carta L, Smaldone S, Zilberberg L et al (2009) p38 MAPK is an early determinant of promiscuous Smad2\/3 signaling in the aortas of fibrillin-1 (Fbn1)-null mice. J Biol Chem 284(9):5630\u20135636. doi: 10.1074\/jbc.M806962200","journal-title":"J Biol Chem"},{"issue":"5770","key":"2324_CR35","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1126\/science.1124287","volume":"312","author":"JP Habashi","year":"2006","unstructured":"Habashi JP, Judge DP, Holm TM et al (2006) Losartan, an AT1 antagonist, prevents aortic aneurysm in a mouse model of Marfan syndrome. Science 312(5770):117\u2013121. doi: 10.1126\/science.1124287","journal-title":"Science"},{"issue":"11","key":"2324_CR36","doi-asserted-by":"publisher","first-page":"1586","DOI":"10.1172\/JCI22715","volume":"114","author":"CM Ng","year":"2004","unstructured":"Ng CM, Cheng A, Myers LA et al (2004) TGF-beta-dependent pathogenesis of mitral valve prolapse in a mouse model of Marfan syndrome. J Clin Invest 114(11):1586\u20131592. doi: 10.1172\/JCI22715","journal-title":"J Clin Invest"},{"issue":"8","key":"2324_CR37","doi-asserted-by":"publisher","first-page":"916","DOI":"10.1038\/ng.2348","volume":"44","author":"C Boileau","year":"2012","unstructured":"Boileau C, Guo DC, Hanna N et al (2012) TGFB2 mutations cause familial thoracic aortic aneurysms and dissections associated with mild systemic features of Marfan syndrome. Nat Genet 44(8):916\u2013921. doi: 10.1038\/ng.2348","journal-title":"Nat Genet"},{"issue":"8","key":"2324_CR38","doi-asserted-by":"publisher","first-page":"922","DOI":"10.1038\/ng.2349","volume":"44","author":"ME Lindsay","year":"2012","unstructured":"Lindsay ME, Schepers D, Bolar NA et al (2012) Loss-of-function mutations in TGFB2 cause a syndromic presentation of thoracic aortic aneurysm. Nat Genet 44(8):922\u2013927. doi: 10.1038\/ng.2349","journal-title":"Nat Genet"},{"issue":"4","key":"2324_CR39","doi-asserted-by":"publisher","first-page":"911","DOI":"10.1161\/ATVBAHA.114.305150","volume":"35","author":"JR Cook","year":"2015","unstructured":"Cook JR, Clayton NP, Carta L et al (2015) Dimorphic effects of transforming growth factor-beta signaling during aortic aneurysm progression in mice suggest a combinatorial therapy for Marfan syndrome. Arterioscler Thromb Vasc Biol 35(4):911\u2013917. doi: 10.1161\/ATVBAHA.114.305150","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"1","key":"2324_CR40","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1016\/j.ydbio.2008.07.038","volume":"322","author":"S Sridurongrit","year":"2008","unstructured":"Sridurongrit S, Larsson J, Schwartz R et al (2008) Signaling via the Tgf-beta type I receptor Alk5 in heart development. Dev Biol 322(1):208\u2013218. doi: 10.1016\/j.ydbio.2008.07.038","journal-title":"Dev Biol"},{"issue":"8","key":"2324_CR41","doi-asserted-by":"crossref","first-page":"1843","DOI":"10.1161\/01.ATV.19.8.1843","volume":"19","author":"CM Ford","year":"1999","unstructured":"Ford CM, Li S, Pickering JG (1999) Angiotensin II stimulates collagen synthesis in human vascular smooth muscle cells. Involvement of the AT(1) receptor, transforming growth factor-beta, and tyrosine phosphorylation. Arterioscler Thromb Vasc Biol 19(8):1843\u20131851","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"7","key":"2324_CR42","doi-asserted-by":"publisher","first-page":"881","DOI":"10.1161\/CIRCRESAHA.113.301989","volume":"113","author":"D Gomez","year":"2013","unstructured":"Gomez D, Kessler K, Michel JB et al (2013) Modifications of chromatin dynamics control Smad2 pathway activation in aneurysmal smooth muscle cells. Circ Res 113(7):881\u2013890. doi: 10.1161\/CIRCRESAHA.113.301989","journal-title":"Circ Res"},{"issue":"3","key":"2324_CR43","doi-asserted-by":"publisher","first-page":"2441","DOI":"10.1016\/j.ijcard.2013.03.033","volume":"168","author":"R Franken","year":"2013","unstructured":"Franken R, den Hartog AW, de Waard V et al (2013) Circulating transforming growth factor-beta as a prognostic biomarker in Marfan syndrome. Int J Cardiol 168(3):2441\u20132446. doi: 10.1016\/j.ijcard.2013.03.033","journal-title":"Int J Cardiol"},{"issue":"6","key":"2324_CR44","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1038\/ncb1137","volume":"6","author":"Y Zou","year":"2004","unstructured":"Zou Y, Akazawa H, Qin Y et al (2004) Mechanical stress activates angiotensin II type 1 receptor without the involvement of angiotensin II. Nat Cell Biol 6(6):499\u2013506. doi: 10.1038\/ncb1137","journal-title":"Nat Cell Biol"},{"issue":"18","key":"2324_CR45","doi-asserted-by":"crossref","first-page":"2195","DOI":"10.1016\/S0024-3205(02)01998-7","volume":"71","author":"M Nishimoto","year":"2002","unstructured":"Nishimoto M, Takai S, Fukumoto H et al (2002) Increased local angiotensin II formation in aneurysmal aorta. Life Sci 71(18):2195\u20132205","journal-title":"Life Sci"},{"issue":"11","key":"2324_CR46","doi-asserted-by":"publisher","first-page":"1605","DOI":"10.1172\/JCI7818","volume":"105","author":"A Daugherty","year":"2000","unstructured":"Daugherty A, Manning MW, Cassis LA (2000) Angiotensin II promotes atherosclerotic lesions and aneurysms in apolipoprotein E-deficient mice. J Clin Invest 105(11):1605\u20131612. doi: 10.1172\/JCI7818","journal-title":"J Clin Invest"},{"issue":"2","key":"2324_CR47","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1016\/j.coph.2013.01.002","volume":"13","author":"X Chen","year":"2013","unstructured":"Chen X, Lu H, Rateri DL et al (2013) Conundrum of angiotensin II and TGF-beta interactions in aortic aneurysms. Curr Opin Pharmacol 13(2):180\u2013185. doi: 10.1016\/j.coph.2013.01.002","journal-title":"Curr Opin Pharmacol"},{"issue":"5","key":"2324_CR48","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1038\/ki.2008.213","volume":"74","author":"G Carvajal","year":"2008","unstructured":"Carvajal G, Rodriguez-Vita J, Rodrigues-Diez R et al (2008) Angiotensin II activates the Smad pathway during epithelial mesenchymal transdifferentiation. Kidney Int 74(5):585\u2013595. doi: 10.1038\/ki.2008.213","journal-title":"Kidney Int"},{"issue":"19","key":"2324_CR49","doi-asserted-by":"publisher","first-page":"2509","DOI":"10.1161\/01.CIR.0000165133.84978.E2","volume":"111","author":"J Rodriguez-Vita","year":"2005","unstructured":"Rodriguez-Vita J, Sanchez-Lopez E, Esteban V et al (2005) Angiotensin II activates the Smad pathway in vascular smooth muscle cells by a transforming growth factor-beta-independent mechanism. Circulation 111(19):2509\u20132517. doi: 10.1161\/01.CIR.0000165133.84978.E2","journal-title":"Circulation"},{"issue":"2","key":"2324_CR50","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1007\/s12471-014-0622-0","volume":"23","author":"R Franken","year":"2015","unstructured":"Franken R, Radonic T, den Hartog AW et al (2015) The revised role of TGF-beta in aortic aneurysms in Marfan syndrome. Neth Heart J 23(2):116\u2013121. doi: 10.1007\/s12471-014-0622-0","journal-title":"Neth Heart J"},{"issue":"12 Suppl 1","key":"2324_CR51","doi-asserted-by":"crossref","first-page":"I282","DOI":"10.1161\/hc37t1.094856","volume":"104","author":"H Nagashima","year":"2001","unstructured":"Nagashima H, Sakomura Y, Aoka Y et al (2001) Angiotensin II type 2 receptor mediates vascular smooth muscle cell apoptosis in cystic medial degeneration associated with Marfan\u2019s syndrome. Circulation 104(12 Suppl 1):I282\u2013I287","journal-title":"Circulation"},{"issue":"8","key":"2324_CR52","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1038\/nrcardio.2015.95","volume":"12","author":"R Franken","year":"2015","unstructured":"Franken R, Mulder BJ (2015) Aortic disease: Losartan versus atenolol in the Marfan aorta-how to treat? Nat Rev Cardiol 12(8):447\u2013448. doi: 10.1038\/nrcardio.2015.95","journal-title":"Nat Rev Cardiol"},{"key":"2324_CR53","doi-asserted-by":"publisher","first-page":"2015","DOI":"10.1152\/ajpheart.00291.2015","volume":"00291","author":"JW Wisler","year":"2015","unstructured":"Wisler JW, Harris EM, Rasich MC et al (2015) The role of beta-arrestin2-dependent signaling in thoracic aortic aneurysm formation in a murine model of Marfan syndrome. Am J Physiol Heart Circ Physiol ajpheart 00291:2015. doi: 10.1152\/ajpheart.00291.2015","journal-title":"Am J Physiol Heart Circ Physiol ajpheart"},{"issue":"32","key":"2324_CR54","doi-asserted-by":"publisher","first-page":"2160","DOI":"10.1093\/eurheartj\/ehv151","volume":"36","author":"O Milleron","year":"2015","unstructured":"Milleron O, Arnoult F, Ropers J et al (2015) Marfan Sartan: a randomized, double-blind, placebo-controlled trial. Eur Heart J 36(32):2160\u20132166. doi: 10.1093\/eurheartj\/ehv151","journal-title":"Eur Heart J"},{"issue":"3","key":"2324_CR55","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1016\/j.mayocp.2012.11.005","volume":"88","author":"HH Chiu","year":"2013","unstructured":"Chiu HH, Wu MH, Wang JK et al (2013) Losartan added to beta-blockade therapy for aortic root dilation in Marfan syndrome: a randomized, open-label pilot study. Mayo Clin Proc 88(3):271\u2013276. doi: 10.1016\/j.mayocp.2012.11.005","journal-title":"Mayo Clin Proc"},{"issue":"22","key":"2324_CR56","doi-asserted-by":"publisher","first-page":"2061","DOI":"10.1056\/NEJMoa1404731","volume":"371","author":"RV Lacro","year":"2014","unstructured":"Lacro RV, Dietz HC, Sleeper LA et al (2014) Atenolol versus losartan in children and young adults with Marfan\u2019s syndrome. N Engl J Med 371(22):2061\u20132071. doi: 10.1056\/NEJMoa1404731","journal-title":"N Engl J Med"},{"issue":"45","key":"2324_CR57","doi-asserted-by":"publisher","first-page":"3491","DOI":"10.1093\/eurheartj\/eht334","volume":"34","author":"M Groenink","year":"2013","unstructured":"Groenink M, den Hartog AW, Franken R et al (2013) Losartan reduces aortic dilatation rate in adults with Marfan syndrome: a randomized controlled trial. Eur Heart J 34(45):3491\u20133500. doi: 10.1093\/eurheartj\/eht334","journal-title":"Eur Heart J"},{"issue":"2","key":"2324_CR58","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1161\/CIRCGENETICS.114.000950","volume":"8","author":"R Franken","year":"2015","unstructured":"Franken R, den Hartog AW, Radonic T et al (2015) Beneficial outcome of losartan therapy depends on type of FBN1 mutation in Marfan syndrome. Circ Cardiovasc Genet 8(2):383\u2013388. doi: 10.1161\/CIRCGENETICS.114.000950","journal-title":"Circ Cardiovasc Genet"},{"issue":"19 Suppl","key":"2324_CR59","first-page":"II331","volume":"98","author":"AM Segura","year":"1998","unstructured":"Segura AM, Luna RE, Horiba K et al (1998) Immunohistochemistry of matrix metalloproteinases and their inhibitors in thoracic aortic aneurysms and aortic valves of patients with Marfan\u2019s syndrome. Circulation 98(19 Suppl):II331\u2013II337 (discussion II337\u20138)","journal-title":"Circulation"},{"issue":"1\u20132","key":"2324_CR60","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1007\/s00439-004-1194-7","volume":"116","author":"P Booms","year":"2005","unstructured":"Booms P, Pregla R, Ney A et al (2005) RGD-containing fibrillin-1 fragments upregulate matrix metalloproteinase expression in cell culture: a potential factor in the pathogenesis of the Marfan syndrome. Hum Genet 116(1\u20132):51\u201361. doi: 10.1007\/s00439-004-1194-7","journal-title":"Hum Genet"},{"issue":"1 Suppl","key":"2324_CR61","doi-asserted-by":"publisher","first-page":"I365","DOI":"10.1161\/CIRCULATIONAHA.105.000810","volume":"114","author":"JS Ikonomidis","year":"2006","unstructured":"Ikonomidis JS, Jones JA, Barbour JR et al (2006) Expression of matrix metalloproteinases and endogenous inhibitors within ascending aortic aneurysms of patients with Marfan syndrome. Circulation 114(1 Suppl):I365\u2013I370. doi: 10.1161\/CIRCULATIONAHA.105.000810","journal-title":"Circulation"},{"issue":"5","key":"2324_CR62","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1161\/CIRCRESAHA.107.157776","volume":"101","author":"AW Chung","year":"2007","unstructured":"Chung AW, Au Yeung K, Sandor GG et al (2007) Loss of elastic fiber integrity and reduction of vascular smooth muscle contraction resulting from the upregulated activities of matrix metalloproteinase-2 and -9 in the thoracic aortic aneurysm in Marfan syndrome. Circ Res 101(5):512\u2013522. doi: 10.1161\/CIRCRESAHA.107.157776","journal-title":"Circ Res"},{"issue":"8","key":"2324_CR63","doi-asserted-by":"publisher","first-page":"e73","DOI":"10.1161\/CIRCRESAHA.108.174367","volume":"102","author":"AW Chung","year":"2008","unstructured":"Chung AW, Yang HH, Radomski MW et al (2008) Long-term doxycycline is more effective than atenolol to prevent thoracic aortic aneurysm in marfan syndrome through the inhibition of matrix metalloproteinase-2 and -9. Circ Res 102(8):e73\u2013e85. doi: 10.1161\/CIRCRESAHA.108.174367","journal-title":"Circ Res"},{"issue":"12","key":"2324_CR64","doi-asserted-by":"publisher","first-page":"e92","DOI":"10.1161\/CIRCRESAHA.112.268268","volume":"110","author":"W Xiong","year":"2012","unstructured":"Xiong W, Meisinger T, Knispel R et al (2012) MMP-2 regulates Erk1\/2 phosphorylation and aortic dilatation in Marfan syndrome. Circ Res 110(12):e92\u2013e101. doi: 10.1161\/CIRCRESAHA.112.268268","journal-title":"Circ Res"},{"issue":"11","key":"2324_CR65","doi-asserted-by":"publisher","first-page":"983","DOI":"10.1161\/CIRCULATIONAHA.108.843516","volume":"120","author":"C Pilop","year":"2009","unstructured":"Pilop C, Aregger F, Gorman RC et al (2009) Proteomic analysis in aortic media of patients with Marfan syndrome reveals increased activity of calpain 2 in aortic aneurysms. Circulation 120(11):983\u2013991. doi: 10.1161\/CIRCULATIONAHA.108.843516","journal-title":"Circulation"},{"issue":"2","key":"2324_CR66","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1096\/fj.07-8853com","volume":"22","author":"DG Sedding","year":"2008","unstructured":"Sedding DG, Homann M, Seay U et al (2008) Calpain counteracts mechanosensitive apoptosis of vascular smooth muscle cells in vitro and in vivo. FASEB J 22(2):579\u2013589. doi: 10.1096\/fj.07-8853com","journal-title":"FASEB J"},{"issue":"2","key":"2324_CR67","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1161\/CIRCRESAHA.111.253740","volume":"110","author":"DR Merk","year":"2012","unstructured":"Merk DR, Chin JT, Dake BA et al (2012) miR-29b participates in early aneurysm development in Marfan syndrome. Circ Res 110(2):312\u2013324. doi: 10.1161\/CIRCRESAHA.111.253740","journal-title":"Circ Res"},{"issue":"1","key":"2324_CR68","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1161\/ATVBAHA.114.304364","volume":"35","author":"FC Emrich","year":"2015","unstructured":"Emrich FC, Okamura H, Dalal AR et al (2015) Enhanced caspase activity contributes to aortic wall remodeling and early aneurysm development in a murine model of Marfan syndrome. Arterioscler Thromb Vasc Biol 35(1):146\u2013154. doi: 10.1161\/ATVBAHA.114.304364","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"1\u20133","key":"2324_CR69","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1016\/S0014-5793(04)00185-1","volume":"562","author":"WF Tseng","year":"2004","unstructured":"Tseng WF, Huang SS, Huang JS (2004) LRP-1\/TbetaR-V mediates TGF-beta1-induced growth inhibition in CHO cells. FEBS Lett 562(1\u20133):71\u201378. doi: 10.1016\/S0014-5793(04)00185-1","journal-title":"FEBS Lett"},{"issue":"14","key":"2324_CR70","doi-asserted-by":"publisher","first-page":"2068","DOI":"10.1096\/fj.03-0256com","volume":"17","author":"SS Huang","year":"2003","unstructured":"Huang SS, Ling TY, Tseng WF et al (2003) Cellular growth inhibition by IGFBP-3 and TGF-beta1 requires LRP-1. FASEB J 17(14):2068\u20132081. doi: 10.1096\/fj.03-0256com","journal-title":"FASEB J"},{"issue":"5","key":"2324_CR71","doi-asserted-by":"publisher","first-page":"e448","DOI":"10.1371\/journal.pone.0000448","volume":"2","author":"P Boucher","year":"2007","unstructured":"Boucher P, Li WP, Matz RL et al (2007) LRP1 functions as an atheroprotective integrator of TGFbeta and PDFG signals in the vascular wall: implications for Marfan syndrome. PLoS One 2(5):e448. doi: 10.1371\/journal.pone.0000448","journal-title":"PLoS One"},{"issue":"11","key":"2324_CR72","doi-asserted-by":"publisher","first-page":"e82026","DOI":"10.1371\/journal.pone.0082026","volume":"8","author":"JE Basford","year":"2013","unstructured":"Basford JE, Koch S, Anjak A et al (2013) Smooth muscle LDL receptor-related protein-1 deletion induces aortic insufficiency and promotes vascular cardiomyopathy in mice. PLoS One 8(11):e82026. doi: 10.1371\/journal.pone.0082026","journal-title":"PLoS One"},{"issue":"9","key":"2324_CR73","doi-asserted-by":"publisher","first-page":"e6922","DOI":"10.1371\/journal.pone.0006922","volume":"4","author":"L Zhou","year":"2009","unstructured":"Zhou L, Takayama Y, Boucher P et al (2009) LRP1 regulates architecture of the vascular wall by controlling PDGFRbeta-dependent phosphatidylinositol 3-kinase activation. PLoS One 4(9):e6922. doi: 10.1371\/journal.pone.0006922","journal-title":"PLoS One"},{"issue":"3","key":"2324_CR74","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/S0014-2999(03)01556-5","volume":"466","author":"D Bruemmer","year":"2003","unstructured":"Bruemmer D, Berger JP, Liu J et al (2003) A non-thiazolidinedione partial peroxisome proliferator-activated receptor gamma ligand inhibits vascular smooth muscle cell growth. Eur J Pharmacol 466(3):225\u2013234","journal-title":"Eur J Pharmacol"},{"issue":"3","key":"2324_CR75","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1161\/CIRCRESAHA.107.164384","volume":"102","author":"SZ Duan","year":"2008","unstructured":"Duan SZ, Usher MG, Mortensen RM (2008) Peroxisome proliferator-activated receptor-gamma-mediated effects in the vasculature. Circ Res 102(3):283\u2013294. doi: 10.1161\/CIRCRESAHA.107.164384","journal-title":"Circ Res"},{"issue":"3","key":"2324_CR76","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/S0014-2999(00)00758-5","volume":"407","author":"T Okura","year":"2000","unstructured":"Okura T, Nakamura M, Takata Y et al (2000) Troglitazone induces apoptosis via the p53 and Gadd45 pathway in vascular smooth muscle cells. Eur J Pharmacol 407(3):227\u2013235","journal-title":"Eur J Pharmacol"},{"issue":"3","key":"2324_CR77","doi-asserted-by":"crossref","first-page":"811","DOI":"10.2337\/diabetes.54.3.811","volume":"54","author":"S Redondo","year":"2005","unstructured":"Redondo S, Ruiz E, Santos-Gallego CG et al (2005) Pioglitazone induces vascular smooth muscle cell apoptosis through a peroxisome proliferator-activated receptor-gamma, transforming growth factor-beta1, and a Smad2-dependent mechanism. Diabetes 54(3):811\u2013817","journal-title":"Diabetes"},{"issue":"12 Suppl 1","key":"2324_CR78","first-page":"I259","volume":"106","author":"Y Sakomura","year":"2002","unstructured":"Sakomura Y, Nagashima H, Aoka Y et al (2002) Expression of peroxisome proliferator-activated receptor-gamma in vascular smooth muscle cells is upregulated in cystic medial degeneration of annuloaortic ectasia in Marfan syndrome. Circulation 106(12 Suppl 1):I259\u2013I263","journal-title":"Circulation"},{"issue":"49","key":"2324_CR79","doi-asserted-by":"publisher","first-page":"45888","DOI":"10.1074\/jbc.M105490200","volume":"276","author":"M Fu","year":"2001","unstructured":"Fu M, Zhang J, Zhu X et al (2001) Peroxisome proliferator-activated receptor gamma inhibits transforming growth factor beta-induced connective tissue growth factor expression in human aortic smooth muscle cells by interfering with Smad3. J Biol Chem 276(49):45888\u201345894. doi: 10.1074\/jbc.M105490200","journal-title":"J Biol Chem"},{"issue":"8","key":"2324_CR80","doi-asserted-by":"publisher","first-page":"1897","DOI":"10.1172\/JCI118991","volume":"98","author":"RE Law","year":"1996","unstructured":"Law RE, Meehan WP, Xi XP et al (1996) Troglitazone inhibits vascular smooth muscle cell growth and intimal hyperplasia. J Clin Invest 98(8):1897\u20131905. doi: 10.1172\/JCI118991","journal-title":"J Clin Invest"},{"issue":"4","key":"2324_CR81","doi-asserted-by":"publisher","first-page":"674","DOI":"10.1267\/THRO04040674","volume":"91","author":"A Zirlik","year":"2004","unstructured":"Zirlik A, Leugers A, Lohrmann J et al (2004) Direct attenuation of plasminogen activator inhibitor type-1 expression in human adipose tissue by thiazolidinediones. Thromb Haemost 91(4):674\u2013682. doi: 10.1267\/THRO04040674","journal-title":"Thromb Haemost"},{"issue":"4","key":"2324_CR82","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1093\/cvr\/cvn156","volume":"79","author":"C Urbich","year":"2008","unstructured":"Urbich C, Kuehbacher A, Dimmeler S (2008) Role of microRNAs in vascular diseases, inflammation, and angiogenesis. Cardiovasc Res 79(4):581\u2013588. doi: 10.1093\/cvr\/cvn156","journal-title":"Cardiovasc Res"},{"issue":"2","key":"2324_CR83","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1172\/JCI61598","volume":"122","author":"L Maegdefessel","year":"2012","unstructured":"Maegdefessel L, Azuma J, Toh R et al (2012) Inhibition of microRNA-29b reduces murine abdominal aortic aneurysm development. J Clin Invest 122(2):497\u2013506. doi: 10.1172\/JCI61598","journal-title":"J Clin Invest"},{"issue":"6","key":"2324_CR84","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1161\/CIRCGENETICS.111.960419","volume":"4","author":"JA Jones","year":"2011","unstructured":"Jones JA, Stroud RE, O\u2019Quinn EC et al (2011) Selective microRNA suppression in human thoracic aneurysms: relationship of miR-29a to aortic size and proteolytic induction. Circ Cardiovasc Genet 4(6):605\u2013613. doi: 10.1161\/CIRCGENETICS.111.960419","journal-title":"Circ Cardiovasc Genet"},{"issue":"10","key":"2324_CR85","doi-asserted-by":"publisher","first-page":"1115","DOI":"10.1161\/CIRCRESAHA.111.255737","volume":"109","author":"RA Boon","year":"2011","unstructured":"Boon RA, Seeger T, Heydt S et al (2011) MicroRNA-29 in aortic dilation: implications for aneurysm formation. Circ Res 109(10):1115\u20131119. doi: 10.1161\/CIRCRESAHA.111.255737","journal-title":"Circ Res"},{"issue":"6183","key":"2324_CR86","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1126\/science.1253026","volume":"344","author":"JD Humphrey","year":"2014","unstructured":"Humphrey JD, Milewicz DM, Tellides G et al (2014) Cell biology. Dysfunctional mechanosensing in aneurysms. Science 344(6183):477\u2013479. doi: 10.1126\/science.1253026","journal-title":"Dysfunctional mechanosensing in aneurysms. Science"},{"issue":"4226","key":"2324_CR87","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1126\/science.128820","volume":"191","author":"DY Leung","year":"1976","unstructured":"Leung DY, Glagov S, Mathews MB (1976) Cyclic stretching stimulates synthesis of matrix components by arterial smooth muscle cells in vitro. Science 191(4226):475\u2013477","journal-title":"Science"},{"issue":"3","key":"2324_CR88","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1016\/S0002-9440(10)63464-5","volume":"163","author":"S Li","year":"2003","unstructured":"Li S, Van Den Diepstraten C, D\u2019Souza SJ et al (2003) Vascular smooth muscle cells orchestrate the assembly of type I collagen via alpha2beta1 integrin, RhoA, and fibronectin polymerization. Am J Pathol 163(3):1045\u20131056","journal-title":"Am J Pathol"},{"issue":"12","key":"2324_CR89","doi-asserted-by":"publisher","first-page":"a005066","DOI":"10.1101\/cshperspect.a005066","volume":"2","author":"MA Schwartz","year":"2010","unstructured":"Schwartz MA (2010) Integrins and extracellular matrix in mechanotransduction. Cold Spring Harb Perspect Biol 2(12):a005066. doi: 10.1101\/cshperspect.a005066","journal-title":"Cold Spring Harb Perspect Biol"},{"issue":"1","key":"2324_CR90","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/(SICI)1097-0185(20000101)258:1<1::AID-AR1>3.0.CO;2-7","volume":"258","author":"KP Dingemans","year":"2000","unstructured":"Dingemans KP, Teeling P, Lagendijk JH et al (2000) Extracellular matrix of the human aortic media: an ultrastructural histochemical and immunohistochemical study of the adult aortic media. Anat Rec 258(1):1\u201314","journal-title":"Anat Rec"},{"issue":"7","key":"2324_CR91","doi-asserted-by":"crossref","first-page":"3819","DOI":"10.1073\/pnas.96.7.3819","volume":"96","author":"L Pereira","year":"1999","unstructured":"Pereira L, Lee SY, Gayraud B et al (1999) Pathogenetic sequence for aneurysm revealed in mice underexpressing fibrillin-1. Proc Natl Acad Sci USA 96(7):3819\u20133823","journal-title":"Proc Natl Acad Sci USA"},{"issue":"6682","key":"2324_CR92","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1038\/30522","volume":"393","author":"DY Li","year":"1998","unstructured":"Li DY, Brooke B, Davis EC et al (1998) Elastin is an essential determinant of arterial morphogenesis. Nature 393(6682):276\u2013280. doi: 10.1038\/30522","journal-title":"Nature"},{"issue":"7","key":"2324_CR93","doi-asserted-by":"publisher","first-page":"2027","DOI":"10.1007\/s10439-011-0287-4","volume":"39","author":"A Valentin","year":"2011","unstructured":"Valentin A, Humphrey JD, Holzapfel GA (2011) A multi-layered computational model of coupled elastin degradation, vasoactive dysfunction, and collagenous stiffening in aortic aging. Ann Biomed Eng 39(7):2027\u20132045. doi: 10.1007\/s10439-011-0287-4","journal-title":"Ann Biomed Eng"},{"issue":"74","key":"2324_CR94","doi-asserted-by":"publisher","first-page":"2047","DOI":"10.1098\/rsif.2012.0097","volume":"9","author":"JS Wilson","year":"2012","unstructured":"Wilson JS, Baek S, Humphrey JD (2012) Importance of initial aortic properties on the evolving regional anisotropy, stiffness and wall thickness of human abdominal aortic aneurysms. J R Soc Interface 9(74):2047\u20132058. doi: 10.1098\/rsif.2012.0097","journal-title":"J R Soc Interface"},{"issue":"4","key":"2324_CR95","doi-asserted-by":"publisher","first-page":"960","DOI":"10.1161\/ATVBAHA.114.304412","volume":"35","author":"E Crosas-Molist","year":"2015","unstructured":"Crosas-Molist E, Meirelles T, Lopez-Luque J et al (2015) Vascular smooth muscle cell phenotypic changes in patients with Marfan syndrome. Arterioscler Thromb Vasc Biol 35(4):960\u2013972. doi: 10.1161\/ATVBAHA.114.304412","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"4","key":"2324_CR96","first-page":"847","volume":"23","author":"S Takebayashi","year":"1973","unstructured":"Takebayashi S, Kubota I, Takagi T (1973) Ultrastructural and histochemical studies of vascular lesions in Marfan\u2019s syndrome, with report of 4 autopsy cases. Acta Pathol Jpn 23(4):847\u2013866","journal-title":"Acta Pathol Jpn"},{"issue":"11","key":"2324_CR97","first-page":"1433","volume":"38","author":"S Takebayashi","year":"1988","unstructured":"Takebayashi S, Taguchi T, Kawamura K et al (1988) \u201cOsmiophilic elastolysis\u201d of peripheral organ arteries in patients with Marfan\u2019s syndrome. Acta Pathol Jpn 38(11):1433\u20131443","journal-title":"Acta Pathol Jpn"},{"issue":"4","key":"2324_CR98","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1016\/j.carpath.2006.03.004","volume":"15","author":"KP Dingemans","year":"2006","unstructured":"Dingemans KP, Teeling P, van der Wal AC et al (2006) Ultrastructural pathology of aortic dissections in patients with Marfan syndrome: comparison with dissections in patients without Marfan syndrome. Cardiovasc Pathol 15(4):203\u2013212. doi: 10.1016\/j.carpath.2006.03.004","journal-title":"Cardiovasc Pathol"},{"issue":"6","key":"2324_CR99","doi-asserted-by":"publisher","first-page":"1093","DOI":"10.1007\/s10439-009-9686-1","volume":"37","author":"JF Eberth","year":"2009","unstructured":"Eberth JF, Taucer AI, Wilson E et al (2009) Mechanics of carotid arteries in a mouse model of Marfan Syndrome. Ann Biomed Eng 37(6):1093\u20131104. doi: 10.1007\/s10439-009-9686-1","journal-title":"Ann Biomed Eng"},{"issue":"6","key":"2324_CR100","doi-asserted-by":"publisher","first-page":"1597","DOI":"10.1111\/j.1476-5381.2009.00439.x","volume":"158","author":"HT Syyong","year":"2009","unstructured":"Syyong HT, Chung AW, Yang HH et al (2009) Dysfunction of endothelial and smooth muscle cells in small arteries of a mouse model of Marfan syndrome. Br J Pharmacol 158(6):1597\u20131608. doi: 10.1111\/j.1476-5381.2009.00439.x","journal-title":"Br J Pharmacol"},{"issue":"2","key":"2324_CR101","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1159\/000318804","volume":"48","author":"HT Syyong","year":"2011","unstructured":"Syyong HT, Chung AW, van Breemen C (2011) Marfan syndrome decreases Ca2+ wave frequency and vasoconstriction in murine mesenteric resistance arteries without changing underlying mechanisms. J Vasc Res 48(2):150\u2013162. doi: 10.1159\/000318804","journal-title":"J Vasc Res"}],"container-title":["Cellular and Molecular Life Sciences"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00018-016-2324-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00018-016-2324-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00018-016-2324-9","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00018-016-2324-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,6,24]],"date-time":"2017-06-24T16:53:22Z","timestamp":1498323202000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00018-016-2324-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,8,17]]},"references-count":101,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2017,1]]}},"alternative-id":["2324"],"URL":"https:\/\/doi.org\/10.1007\/s00018-016-2324-9","relation":{},"ISSN":["1420-682X","1420-9071"],"issn-type":[{"value":"1420-682X","type":"print"},{"value":"1420-9071","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,8,17]]}}}